[go: up one dir, main page]

TW372238B - N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics - Google Patents

N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics

Info

Publication number
TW372238B
TW372238B TW085106988A TW85106988A TW372238B TW 372238 B TW372238 B TW 372238B TW 085106988 A TW085106988 A TW 085106988A TW 85106988 A TW85106988 A TW 85106988A TW 372238 B TW372238 B TW 372238B
Authority
TW
Taiwan
Prior art keywords
therapeutics
diazabicyclo
oct
methyl
preparation
Prior art date
Application number
TW085106988A
Other languages
English (en)
Inventor
Samir Jegham
Jean Jacques Koenig
Alistair Lochead
Alain Nedelec
Yves Guminski
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of TW372238B publication Critical patent/TW372238B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
    • C07D245/02—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
TW085106988A 1995-06-13 1996-06-11 N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics TW372238B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9506951A FR2735475B1 (fr) 1995-06-13 1995-06-13 Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
TW372238B true TW372238B (en) 1999-10-21

Family

ID=9479885

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085106988A TW372238B (en) 1995-06-13 1996-06-11 N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics

Country Status (19)

Country Link
US (1) US5663173A (zh)
EP (1) EP0748807A1 (zh)
JP (1) JPH09118680A (zh)
KR (1) KR970001335A (zh)
CN (1) CN1143644A (zh)
AR (1) AR004669A1 (zh)
AU (1) AU704388B2 (zh)
CA (1) CA2178849A1 (zh)
CO (1) CO4700470A1 (zh)
CZ (1) CZ171696A3 (zh)
FR (1) FR2735475B1 (zh)
HU (1) HUP9601620A3 (zh)
IL (1) IL118644A (zh)
NO (1) NO305251B1 (zh)
NZ (1) NZ286805A (zh)
PL (1) PL314745A1 (zh)
SK (1) SK75296A3 (zh)
TW (1) TW372238B (zh)
ZA (1) ZA964985B (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2756564B1 (fr) * 1996-12-04 2004-05-14 Synthelabo Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
FR2756563B1 (fr) * 1996-12-04 1998-12-24 Synthelabo Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
ATE359994T1 (de) 1997-11-07 2007-05-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonen
EP1464333A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
EP1468685A3 (en) * 1998-06-15 2004-12-15 Sepracor Inc. Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
CZ20004736A3 (cs) 1998-06-15 2001-09-12 Sepracor, Inc. Farmaceutický prostředek
IL140118A0 (en) 1998-06-15 2002-02-10 Sepracor Inc Use of optically pure (+) norcisapride for treating apnea, bulimia and other disorders
US6353005B1 (en) 1999-03-02 2002-03-05 Sepracor, Inc. Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
US6362202B1 (en) 1999-03-02 2002-03-26 Sepracor Inc. Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
WO2005118537A2 (en) * 2004-05-31 2005-12-15 Ranbaxy Laboratories Limited Arylpiperazine derivatives as adrenergic receptor antagonists
TW201026695A (en) 2008-12-12 2010-07-16 Astrazeneca Ab Piperidine compounds and uses thereof-596
JP5549847B2 (ja) * 2009-11-16 2014-07-16 東ソー株式会社 Ｎ−（２−アルコキシメチル）トリエチレンジアミン類の製造法
GB201219820D0 (en) 2012-11-05 2012-12-19 Isis Innovation Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
HUT70154A (en) * 1991-09-12 1995-09-28 Smithkline Beecham Plc 5-ht4 receptor antagonists and pharmaceutical compositions containing them
TW282460B (zh) * 1993-12-28 1996-08-01 Yamanouchi Pharma Co Ltd

Also Published As

Publication number Publication date
AU5591296A (en) 1997-01-02
SK75296A3 (en) 1997-05-07
CN1143644A (zh) 1997-02-26
KR970001335A (ko) 1997-01-24
ZA964985B (en) 1997-01-23
HU9601620D0 (en) 1996-08-28
US5663173A (en) 1997-09-02
IL118644A (en) 2000-02-17
NO962477D0 (no) 1996-06-12
PL314745A1 (en) 1996-12-23
JPH09118680A (ja) 1997-05-06
MX9602306A (es) 1997-10-31
CA2178849A1 (en) 1996-12-14
CZ171696A3 (en) 1997-01-15
AR004669A1 (es) 1999-03-10
FR2735475A1 (fr) 1996-12-20
FR2735475B1 (fr) 1997-07-11
HUP9601620A3 (en) 1998-07-28
NZ286805A (en) 1998-03-25
EP0748807A1 (fr) 1996-12-18
CO4700470A1 (es) 1998-12-29
HUP9601620A2 (en) 1997-01-28
AU704388B2 (en) 1999-04-22
NO305251B1 (no) 1999-04-26
NO962477L (no) 1996-12-16
IL118644A0 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
TW372238B (en) N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
TW336939B (en) Lipopeptide derivatives, a process for their preparation and their use
GB9408185D0 (en) New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
ITMI930850A1 (it) Procedimento di purificazione dell'idrogeno e purificatore relativo
TW340109B (en) Amide derivatives and their therapeutic use
HUP0204354A2 (hu) Új heterociklusos vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
SI0688771T1 (en) Use of lactam compounds as pharmaceutical agents
ZA893651B (en) 6-phenyl-3-(piperazinylalkyl)-2,4(1h,3h)-pyrimidinedione derivatives,their preparation and their application in therapy
ZA956477B (en) N-substituted 3-azabicyclo[3.2.0] heptane derivatives, the preparation and use thereof.
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
LV12045A (lv) N-monoaizvietotu un N,N'-divaizvietotu nesimetrisku ciklisku urinvielas atvasinajumu iegusanas panemiens
MY111474A (en) Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders.
SG58291G (en) Anticonvulsant agents
MX9603199A (es) Antagonistas de receptores a endotelina.
DK7286A (da) Octahydroindoliziner
DK0772630T3 (da) Streptograminderivater, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
SE9603284D0 (sv) New compounds
TR200001976T2 (tr) İzopropil-Metil [2-(3-n-propoksifenoksi)etil] amin'in hazırlanmasına yönelik usul
TR199800958A2 (xx) Herbisidal 3,5-Difloropridinleri.
IL109655A0 (en) 2-Aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics
DE69733316D1 (de) Herstellung von 3-fluoroxindolderivaten
UA10504A (uk) N-(п-hітрофеhілсульфоhіл)біцикло[2.2.1]гепт-2-єhіл -еhдо-5-метиламіh, який має аhальгетичhу, протисудорожhу та траhквілізуючу дію